Priority Applications (3) Applications Claiming Priority (2) Publications (2) Family ID=76250387 Family Applications (1) Country Status (4) Cited By (5) Families Citing this family (4) Citations (4) Family Cites Families (3) 2021 2021-04-09 WO PCT/IB2021/052948 patent/WO2021205388A2/en not_active Ceased 2021-04-09 CN CN202180023419.7A patent/CN115315438A/en active Pending 2021-04-09 US US17/995,857 patent/US12552742B2/en active Active 2021-04-09 EP EP21729629.2A patent/EP4132960A2/en active Pending
This synthetic peptide fragment derived from human growth hormone (amino acids 176-191) has been specifically engineered to isolate the fat-metabolizing properties of growth hormone while completely eliminating effects on insulin-like growth factor 1 (IGF-1), blood glucose regulation, and tissue growth
Enjoy free, convenient returns on purchases within seven days Need assistance
Ardelyxs revamped New Drug Application included data from the Phase III PHREEDOM, BLOCK and AMPLIFY studies, all of which met their primary efficacy endpoints
How to Access PT-141 PT-141 requires a prescription and should be used under medical supervision
The good news is that as you lose the extra body fat, you decrease your overall inflammation and generally feel a lot more energetic and able to exercise